Aarti Pharmalabs Limited Financial Ratios
AARTIPHARM · Healthcare · Current price ₹876.95
P/E ratio
45.5x
P/B ratio
3.5x
ROE
8.1%
ROCE
9.7%
Debt / Equity
0.36
Dividend yield
0.4%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | 45.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 3.5x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | 8.1% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | 9.7% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.36 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with Aarti Pharmalabs Limited's latest numbers.
Aarti Pharmalabs Limited profitability
Aarti Pharmalabs Limited generates a return on equity of 8.1% and a return on capital employed of 9.7%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.36 and a P/E of 45.5x, Aarti Pharmalabs Limited is conservatively financed. Our overall business-quality score for the company is 2.6 / 10.
Understand the ratios
More on Aarti Pharmalabs Limited
DocStoX estimates are computed from reported financials, for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.